Literature DB >> 18308638

Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections.

Jin S Im1, Tae-Jin Kang, Seong-Beom Lee, Chi-Hong Kim, Sang-Haak Lee, Manjunatha M Venkataswamy, Evan R Serfass, Bing Chen, Petr A Illarionov, Gurdyal S Besra, William R Jacobs, Gue-Tae Chae, Steven A Porcelli.   

Abstract

CD1d-restricted invariant natural killer T cells (iNKT cells) have been identified as an important type of effector and regulatory T cell, but their roles in the chronic infectious diseases caused by Mycobacterium tuberculosis and Mycobacterium leprae remain poorly defined. Here, we studied circulating human iNKT cells in blood samples from tuberculosis (TB) and leprosy patients. We found that the percentages of iNKT cells among total circulating T cells in TB and leprosy patients were not significantly different from those in normal controls. However, both TB and leprosy patients showed a selective reduction of the proinflammatory CD4(-)CD8beta(-) (DN) iNKT cells with a proportionate increase in the CD4(+) iNKT cells. Similar phenotypic alterations in circulating iNKT cells were observed in a mouse model of M. tuberculosis infection. Taken together, these findings indicate that the selective reduction of circulating DN iNKT cells is associated with chronic infections caused by M. tuberculosis and M. leprae.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308638      PMCID: PMC2413133          DOI: 10.1016/j.clim.2007.12.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  51 in total

1.  Effects of stepwise cryodilution prior to freezing and stepwise post-thaw rehydration on viability of ovine embryos.

Authors:  C L Smith; A T Peter; K M Appell
Journal:  Theriogenology       Date:  1994       Impact factor: 2.740

2.  Multiple immuno-regulatory defects in type-1 diabetes.

Authors:  Anjli Kukreja; Giulia Cost; John Marker; Chenhui Zhang; Zhong Sun; Karen Lin-Su; Svetlana Ten; Maureen Sanz; Mark Exley; Brian Wilson; Steven Porcelli; Noel Maclaren
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment.

Authors:  Warly Barcelos; Olindo Assis Martins-Filho; Tânia Mara Pinto Dabés Guimarães; Márcio Hamilton Prostzner Oliveira; Silvana Spíndola-de-Miranda; Beatriz Nascimento Carvalho; Vicente de Paulo Coelho Peixoto de Toledo
Journal:  Microbiol Immunol       Date:  2006       Impact factor: 1.955

4.  Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.

Authors:  Stephan D Gadola; Nicolas Dulphy; Mariolina Salio; Vincenzo Cerundolo
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

5.  Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

Authors:  S B Wilson; S C Kent; K T Patton; T Orban; R A Jackson; M Exley; S Porcelli; D A Schatz; M A Atkinson; S P Balk; J L Strominger; D A Hafler
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

6.  Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.

Authors:  A O Sousa; R J Mazzaccaro; R G Russell; F K Lee; O C Turner; S Hong; L Van Kaer; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

7.  CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.

Authors:  Xinchun Chen; Boping Zhou; Meizhong Li; Qunyi Deng; Xueqiong Wu; Xiaohua Le; Chi Wu; Nicolas Larmonier; Wei Zhang; Hongmei Zhang; Huosheng Wang; Emmanuel Katsanis
Journal:  Clin Immunol       Date:  2007-01-17       Impact factor: 3.969

8.  Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection.

Authors:  Michiyo Inoue; Tatsuya Kanto; Hideki Miyatake; Ichiyo Itose; Masanori Miyazaki; Takayuki Yakushijin; Mitsuru Sakakibara; Noriyoshi Kuzushita; Naoki Hiramatsu; Tetsuo Takehara; Akinori Kasahara; Norio Hayashi
Journal:  J Hepatol       Date:  2006-02-28       Impact factor: 25.083

9.  Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells.

Authors:  Jennifer E Snyder-Cappione; Douglas F Nixon; Christopher P Loo; Joan M Chapman; Duncan A Meiklejohn; Fernando F Melo; Priscilla R Costa; Johan K Sandberg; Denise S Rodrigues; Esper G Kallas
Journal:  J Infect Dis       Date:  2007-03-20       Impact factor: 5.226

Review 10.  Tumor necrosis factor and tuberculosis.

Authors:  Philana Ling Lin; Hillarie L Plessner; Nikolai N Voitenok; JoAnne L Flynn
Journal:  J Investig Dermatol Symp Proc       Date:  2007-05
View more
  25 in total

1.  Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection.

Authors:  Valerie R Stolberg; Bo-chin Chiu; Brian E Martin; Samir A Shah; Matyas Sandor; Stephen W Chensue
Journal:  J Innate Immun       Date:  2010-10-29       Impact factor: 7.349

Review 2.  Optimizing NKT cell ligands as vaccine adjuvants.

Authors:  Leandro J Carreño; Shalu Sharma Kharkwal; Steven A Porcelli
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

3.  Altered peripheral invariant natural killer T cells in atopic dermatitis.

Authors:  Edit Gyimesi; Georgina Nagy; Éva Remenyik; Sándor Sipka; Margit Zeher; Tamás Bíró; Andrea Szegedi
Journal:  J Clin Immunol       Date:  2011-06-21       Impact factor: 8.317

4.  Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection.

Authors:  Charles Kyriakos Vorkas; Matthew F Wipperman; Kelin Li; James Bean; Shakti K Bhattarai; Matthew Adamow; Phillip Wong; Jeffrey Aubé; Marc Antoine Jean Juste; Vanni Bucci; Daniel W Fitzgerald; Michael S Glickman
Journal:  JCI Insight       Date:  2018-10-04

5.  Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells.

Authors:  Xiangshu Wen; Ping Rao; Leandro J Carreño; Seil Kim; Agnieszka Lawrenczyk; Steven A Porcelli; Peter Cresswell; Weiming Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

6.  Immunology of tuberculosis.

Authors:  Qing Zhang; Isamu Sugawara
Journal:  World J Exp Med       Date:  2012-08-20

7.  Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease.

Authors:  Abel Trujillo-Ocampo; Hyun-Woo Cho; Amanda C Herrmann; Wilfredo Ruiz-Vazquez; Andrew B Thornton; Hong He; Dan Li; Mariam A Qazilbash; Qing Ma; Steven A Porcelli; Elizabeth J Shpall; Jeffrey Molldrem; Jin S Im
Journal:  Cytotherapy       Date:  2018-07-31       Impact factor: 5.414

8.  Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.

Authors:  L C Ndhlovu; J E Snyder-Cappione; K I Carvalho; F E Leal; C P Loo; F R Bruno; A R Jha; D Devita; A M Hasenkrug; H M R Barbosa; A C Segurado; D F Nixon; E L Murphy; E G Kallas
Journal:  Clin Exp Immunol       Date:  2009-09-02       Impact factor: 4.330

Review 9.  Nonclassical T cells and their antigens in tuberculosis.

Authors:  Gennaro De Libero; Amit Singhal; Marco Lepore; Lucia Mori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-24       Impact factor: 6.915

10.  Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.

Authors:  Joanne E Croudace; Stuart M Curbishley; Manuela Mura; Carrie R Willcox; Petr A Illarionov; Gurdyal S Besra; David H Adams; David A Lammas
Journal:  BMC Immunol       Date:  2008-12-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.